Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
May 17, 2019
IDEAYA Receives Authorization to Proceed with Phase 1/2 Tissue-Type Agnostic Basket Trial to Treat Patients with Tumors Harboring GNAQ/11 Mutations and PKC Fusions
May 17, 2019
Audentes Therapeutics Announces Launch of New State-of-the-Art Internal cGMP Plasmid Manufacturing Facility
May 17, 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
April 15, 2019
Cidara Selects First Clinical Development Candidate From Its Cloudbreak Influenza (Antiviral) Program
April 11, 2019
NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
April 8, 2019
Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne Muscular Dystrophy and Mytonic Dystrophy
April 4, 2019
Homology Medicines Presents Preclinical Data From PKU Gene Therapy Program Demonstrating Restored Metabolic Pathway And Increased Neurotransmitter Production
April 4, 2019
Homology Medicines Announces FDA Clearance of Investigational New Drug Application for HMI-102 Gene Therapy Candidate for PKU
April 3, 2019
RareCyte Expands Liquid Biopsy Offerings With The RarePlex™ CTC Developer Kit For Custom Biomarkers, And Introduces The Next Generation CytePicker® Cell Retrieval Module For Single Cell And Tissue Micro-Region Retrieval
April 3, 2019
Results From Combination of APR-246 with Immuno-Oncology Agents Presented at the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta
« Previous Page
1
…
53
54
55
56
57
…
103